Lynton RedTouch PRO

Lynton, the UK’s leading provider of aesthetic technologies, has announced the launch of RedTouch PRO, following the initial unveiling at CCR. Uniquely operating at a 675nm wavelength, RedTouch PRO is the only laser system that directly and selectively stimulates collagen, offering an entirely new approach to skin rejuvenation and dermal remodelling, aligned with current consumer demand for regenerative treatments and collagen banking. The official RedTouch PRO launch event will be hosted by Lynton at London’s Tower Bridge on 27 November — an exclusive evening celebrating the science, innovation and future of collagen-focused technologies.

Developed by DEKA and exclusively distributed in the UK by Lynton, RedTouch PRO combines breakthrough science with practical usability. The proprietary 675nm wavelength stimulates collagen types I, III and IV without ablating or damaging the skin. Designed for safe and effective treatment of ageing, skin laxity, uneven tone, and photodamage – the RedTouch PRO is the first and only device using a 675nm laser which is directly absorbed by collagen fibres, making it a highly effective, highly selective rejuvenation without trauma or downtime.

Unlike traditional resurfacing or bulk heating devices, RedTouch PRO has a photobiomodulation effect proven to enhance fibroblast activity, ECM regeneration, and dermal thickness through selective thermal stimulation of collagen. Clinical studies show visible improvements in skin smoothness, firmness and tone after just 3 to 5 sessions, with zero downtime. RedTouch PRO is painless, requires no anaesthesia or consumables, and is suitable for Fitzpatrick skin types 1-5. Treatment protocols are designed to be quick and operator-friendly, supporting a profitable and patient-preferred service in clinic.

The UK launch will be spearheaded by Dr Ariel Haus, who has pioneered early use of the device at his Harley Street clinic. A nationwide clinical faculty programme and launch events will run from October, with initial stock available for pre-order now.

Dr Jon Exley, Managing Director of Lynton, commented:"At Lynton, we’re focused on bringing clinically proven, technology-led solutions to UK practitioners. RedTouch PRO is a genuine category innovation — it opens up a whole new treatment modality based on exclusive collagen targeting at a wavelength that no other laser system can match. We’re excited to partner with DEKA on this UK-first launch and look forward to supporting our partners with training, education and clinical success."

For further information, to request a demonstration or to pre-order RedTouch PRO, contact the Lynton team.